Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Neurochem Int ; 71: 47-55, 2014 May.
Article in English | MEDLINE | ID: mdl-24726768

ABSTRACT

Smoking has been suggested as one of the risk factor for amyotrophic lateral sclerosis (ALS) development. In order to investigate whether adverse effects of cigarette smoke in ALS have any association with increase in oxidative stress, disease severity, lipid hydroperoxides (LPO) and superoxide dismutase-1 (SOD1) levels were measured in biofluids of smoker and never smoker ALS patients and clinically correlated. Serum and CSF from sporadic ALS patients (n=50) diagnosed with El Escorial criteria were collected in the study. Serum (n=50) and CSF (n=42) were also collected from normal healthy controls. The LPO levels were estimated using commercially available kits. Enzyme-linked immunosorbent assays (ELISAs) were used to quantitate SOD1. Their levels were further analyzed among smoker and never smoker subjects. Significantly elevated LPO in sera and CSF of ALS patients were observed (p<0.05). There was considerably increased LPO in sera and CSF of smoker ALS subjects matched with disease severity as compared to never smoker ALS (p<0.05). ALS group did not show any alteration in SOD1 when compared to controls (p>0.05). In addition, no change has been observed in SOD1 levels in ALS subjects who smoke (p>0.05). Increased LPO and unaltered SOD1 in ALS patients may suggest the neuro-pathological association of LPO with ALS disease independent of SOD1. With current findings, it may be proposed that LPO levels might constitute as probable biomarker for smoker ALS patients, however, it cannot be concluded without larger gender matched studies. Additional investigations are needed to determine whether LPO upregulation is primary or secondary to motor neuron degeneration in ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Lipid Peroxides/metabolism , Smoking/metabolism , Adolescent , Adult , Aged , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Female , Humans , Lipid Peroxides/cerebrospinal fluid , Male , Middle Aged , Oxidative Stress , Sex Characteristics , Smoking/cerebrospinal fluid , Superoxide Dismutase/blood , Superoxide Dismutase/cerebrospinal fluid , Superoxide Dismutase-1 , Young Adult
2.
Neuropediatrics ; 40(2): 66-72, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19809934

ABSTRACT

Severe septic illness is often associated with cerebral manifestations such was disturbed consciousness and delirium. Little was known about its effect on the CNS. This is the first study in children that has assessed the direct mediators of brain inflammation and injury with sepsis. The serum and CSF concentrations of soluble intracellular adhesion molecule-1 (sICAM-1) (marker of endothelium-leukocyte interaction), nitric oxide (NO) and lipid peroxide (LPO) (markers for lipid peroxidation) and S-100B protein (marker of astrocytes activation and injury), were measured in 40 children with sepsis of whom 40% had moderate to severe septic encephalopathy. Serum from 25 normal children was used for comparison. Serum values of sICAM-1, NO, LPO and S100B were elevated in patients compared to controls. The greater elevation of the CSF:serum albumin ratio suggests loss of blood-brain barrier integrity. After normalising for CSF:serum albumin ratio, we demonstrated a significant intrathecal synthesis of NO, LPO and S100B. Patients with encephalopathy had elevated serum and CSF levels of sICAM-1, NO, LPO and S100B compared to sepsis only. This study indicates that the brain is vulnerable in children with sepsis. It also suggests that coordinated interactions between immune system, vascular endothelial cells, CNS barriers, astrocytes and brain lipid peroxides, may contribute to septic encephalopathy.


Subject(s)
Cell Adhesion Molecules , Lipid Peroxides , Nerve Growth Factors , S100 Proteins , Sepsis/complications , Adolescent , Analysis of Variance , Brain Diseases/blood , Brain Diseases/cerebrospinal fluid , Brain Diseases/enzymology , Brain Diseases/etiology , Brain Diseases/microbiology , Cell Adhesion Molecules/blood , Cell Adhesion Molecules/cerebrospinal fluid , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Infant , Infant, Newborn , Lipid Peroxides/blood , Lipid Peroxides/cerebrospinal fluid , Male , Nerve Growth Factors/blood , Nerve Growth Factors/cerebrospinal fluid , S100 Calcium Binding Protein beta Subunit , S100 Proteins/blood , S100 Proteins/cerebrospinal fluid , Statistics, Nonparametric
3.
Exp Neurol ; 212(2): 275-84, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18511046

ABSTRACT

Inflammatory responses exacerbate ischemia-reperfusion (IR) injury of spinal cord, although understanding of mediators is incomplete. The major inducible 70kDa heat shock protein (hsp70) is induced by ischemia and extracellular hsp70 (e-hsp70) can modulate inflammatory responses, but there is no published information regarding e-hsp70 levels in the cerebrospinal fluid (CSF) or serum as part of any neurological disease state save trauma. The present work addresses this deficiency by examining e-hsp70 in serum and CSF of dogs in an experimental model of spinal cord IR injury. IR injury of spinal cord caused hind limb paraplegia within 2-3 h that was correlated to lumbosacral poliomalacia with T cell infiltrates at 3 d post-ischemia. In this context, we showed a 5.2-fold elevation of e-hsp70 in CSF that was induced by ischemia and was sustained for the following 3 d observation interval. Plasma e-hsp70 levels were unaffected by IR injury, indicating e-hsp70 release from within the central nervous system. A putative source of this e-hsp70 was ependymal cells in the ischemic penumbra, based upon elevated i-hsp70 levels detected within these cells. Results warrant further investigation of e-hsp70's potential to modulate spinal cord IR injury.


Subject(s)
Gene Expression/physiology , HSP70 Heat-Shock Proteins/blood , HSP70 Heat-Shock Proteins/cerebrospinal fluid , Reperfusion Injury/metabolism , Spinal Cord Ischemia/metabolism , Animals , Disease Models, Animal , Dogs , Gene Expression Regulation/physiology , Granulocyte Colony-Stimulating Factor/metabolism , Interleukin-3/metabolism , Lipid Peroxides/cerebrospinal fluid , Motor Neurons/metabolism , Recombinant Fusion Proteins/metabolism , Recombinant Proteins , Reperfusion Injury/pathology , Spinal Cord/pathology , Spinal Cord Ischemia/pathology , Thromboxane B2/metabolism , Time Factors
4.
Pediatr Neurol ; 35(6): 382-6, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17138006

ABSTRACT

The objective of this study was to investigate the antioxidant/oxidant status of serum and cerebrospinal fluid in children with meningismus and acute bacterial meningitis. Twenty-three children (age range, 0.75 to 9 years) with fever and meningeal signs that required analysis of the cerebrospinal fluid, but no cytologic or biochemical evidence of meningitis in their serum and cerebrospinal fluid, constituted the meningismus group. Thirty-one children (age range, 0.5 to 10 years) with acute bacterial meningitis constituted the meningitis group. Twenty-nine healthy children (age range, 0.5 to 11 years) were recruited as control subjects. Antioxidant status (ascorbic acid, albumin, thiol, uric acid, total bilirubin, total antioxidant capacity, catalase and ceruloplasmin concentrations) and oxidant status (lipid hydroperoxide and total oxidant status) were measured. The serum antioxidant status was lower, and oxidant status levels higher in both meningitis and meningismus subjects than in the control children (P < 0.001). Cerebrospinal fluid oxidant status was lower in the meningitis group than in the meningismus group (P < 0.05). These results indicate that serum antioxidant status was lower, and serum oxidant status was higher in children in the meningismus and meningitis groups, whereas cerebrospinal fluid oxidant status was higher in the meningismus group than in the meningitis group.


Subject(s)
Antioxidants/metabolism , Meningism/metabolism , Meningitis, Bacterial/metabolism , Oxidants/blood , Acute Disease , Ascorbic Acid/blood , Ascorbic Acid/cerebrospinal fluid , Bilirubin/blood , Bilirubin/cerebrospinal fluid , Catalase/blood , Child , Child, Preschool , Female , Glutathione Peroxidase/blood , Humans , Infant , Lipid Peroxides/blood , Lipid Peroxides/cerebrospinal fluid , Male , Malondialdehyde/blood , Oxidants/cerebrospinal fluid , Oxidative Stress , Serum Albumin/metabolism , Sulfhydryl Compounds/blood , Sulfhydryl Compounds/cerebrospinal fluid , Superoxide Dismutase/blood , Uric Acid/blood , Uric Acid/cerebrospinal fluid
5.
Vet Res Commun ; 30(2): 139-47, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16400600

ABSTRACT

Forty-four dogs were referred to our hospital presenting with neurological symptoms such as seizure or paraparesis. Magnetic resonance imaging (MRI) revealed abnormal results in 21 (abnormal MRI group) and normal results in 23 dogs (normal MRI group). Cerebrospinal fluid (CSF) (normal MRI group, n = 22; abnormal MRI group, n = 21) and serum lipid peroxide (LP) concentrations (normal MRI group, n = 11; abnormal MRI group, n = 15) were measured in a number of these dogs, and revealed a significant difference in the CSF/serum LP values (normal MRI group, n = 10; abnormal MRI group, n = 14) between the abnormal and the normal MRI groups (t-test and Mann-Whitney U-test p < 0.05). No other significant differences were observed. CSF/serum LP values exceeding 1.0 were exhibited in 10 of 14 dogs (71%) in the abnormal MRI group, and in 1 of 10 dogs (10%) in the normal MRI group. In the remaining animals, 4 dogs of the abnormal MRI group showed CSF/serum values lower than 1.0, 3 dogs had morphological abnormalities but no abnormal MRI signals in the central nervous system, and 1 dog had an abnormal MRI signal but no pathological abnormality. In the CSF analysis, 3 of 16 dogs (19%) of the abnormal MRI groupshowed abnormal cell counts and/or protein content. We conclude that the CSF/serum LP value can be used for the detection of neurological lesions such as oedema, inflammation and tumour.


Subject(s)
Central Nervous System Diseases/cerebrospinal fluid , Central Nervous System Diseases/veterinary , Dog Diseases/cerebrospinal fluid , Lipid Peroxides/cerebrospinal fluid , Animals , Central Nervous System Diseases/blood , Dog Diseases/blood , Dogs , Female , Lipid Peroxides/blood , Magnetic Resonance Imaging/veterinary , Male
6.
Am J Psychiatry ; 155(9): 1207-13, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9734544

ABSTRACT

OBJECTIVE: Tardive dyskinesia is a movement disorder affecting 20%-40% of patients treated chronically with neuroleptic drugs. The dopamine supersensitivity hypothesis cannot account for the time course of tardive dyskinesia or for the persistence of tardive dyskinesia and the associated structural changes after neuroleptics are discontinued. The authors hypothesized that neuroleptics enhance striatal glutamatergic neurotransmission by blocking presynaptic dopamine receptors, which causes neuronal damage as a consequence of oxidative stress. METHOD: CSF was obtained from 20 patients with schizophrenia, 11 of whom had tardive dyskinesia. Markers for oxidative stress, including superoxide dismutase, lipid hydroperoxide, and protein carbonyl groups, and markers for excitatory neurotransmission, including N-acetylaspartate, N-acetylaspartylglutamate, aspartate, and glutamate, were measured in the CSF specimens. Patients were also rated for tardive dyskinesia symptoms with the Abnormal Involuntary Movement Scale. RESULTS: Tardive dyskinesia patients had significantly higher concentrations of N-acetylaspartate, N-acetylaspartylglutamate, and aspartate in their CSF than patients without tardive dyskinesia when age and neuroleptic dose were controlled for. The significance of the higher levels of protein-oxidized products associated with tardive dyskinesia did not pass Bonferroni correction, however. Tardive dyskinesia symptoms correlated positively with markers of excitatory neurotransmission and protein carbonyl group and negatively with CSF superoxide dismutase activity. CONCLUSIONS: These findings suggest that there are elevated levels of oxidative stress and glutamatergic neurotransmission in tardive dyskinesia, both of which may be relevant to the pathophysiology of tardive dyskinesia.


Subject(s)
Dyskinesia, Drug-Induced/physiopathology , Glutamates/physiology , Oxidative Stress/physiology , Synaptic Transmission/physiology , Adult , Antipsychotic Agents/adverse effects , Aspartic Acid/analogs & derivatives , Aspartic Acid/cerebrospinal fluid , Biomarkers , Corpus Striatum/drug effects , Corpus Striatum/physiopathology , Dipeptides/cerebrospinal fluid , Dopamine Antagonists/pharmacology , Dyskinesia, Drug-Induced/cerebrospinal fluid , Dyskinesia, Drug-Induced/etiology , Female , Glutamates/cerebrospinal fluid , Glutamates/pharmacology , Humans , Lipid Peroxides/cerebrospinal fluid , Male , Middle Aged , Neuropeptides/cerebrospinal fluid , Psychiatric Status Rating Scales/statistics & numerical data , Receptors, Dopamine/drug effects , Schizophrenia/cerebrospinal fluid , Schizophrenia/diagnosis , Schizophrenia/drug therapy , Superoxide Dismutase/cerebrospinal fluid , Synaptic Transmission/drug effects
7.
Indian J Pediatr ; 65(3): 419-27, 1998.
Article in English | MEDLINE | ID: mdl-10771993

ABSTRACT

The study was undertaken to evaluate the role of free oxygen radicals in asphyxiated neonates. Thirty term neonates appropriate for gestational age and with severe birth asphyxia (Apgar score of 3 or less at 1 minute of life) formed the study subjects. The levels of superoxide dismutase (SOD), glutathione peroxidase (GPx), creatine phosphokinase (CPK) and lipid peroxidase (LPO) in the CSF of these neonates were estimated between 12 and 48 hrs of life. Enzyme estimation was performed by standard methods and the results were analysed statistically using Multivariate Logistic Regression analysis and non parametric tests namely Kruskal Wallis test and Wilcoxon's rank sum test. Out of the thirty babies, 14 were observed to be neurologically normal, 9 had significant morbidity and 7 died. The SOD levels ranged from 12.4 to 140 units/ml, GPx from 128 to 1933 nmol/min/dl, CPK from 2 to 2098 IU/dl and LPO from 5.4 to 30.8 umol/hr/dl. The SOD and GPx levels had an inverse relationship whereas rise in LPO and CPK levels were directly proportional to the extent of neurological damage and ultimate clinical outcome. CPK levels higher than 140 IU/ml were lethal and associated with 100% mortality whereas all normal neonates had CPK below 37 IU/ml. The levels of antioxidant enzymes can reliably and significantly predict mortality and morbidity whereas level of an enzyme cannot confidently confer normalcy. Hence antioxidant enzyme levels with a cut off value can be a useful marker and serve as a prognostic indicator in times to come.


Subject(s)
Asphyxia Neonatorum/enzymology , Creatine Kinase/cerebrospinal fluid , Glutathione Peroxidase/cerebrospinal fluid , Lipid Peroxides/cerebrospinal fluid , Reactive Oxygen Species/metabolism , Superoxide Dismutase/cerebrospinal fluid , Asphyxia Neonatorum/mortality , Free Radicals , Humans , Infant, Newborn , Prognosis , Risk Factors , Survival Rate
9.
Clin Chem ; 38(12): 2449-54, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1458583

ABSTRACT

Lipid peroxides were measured in cerebrospinal fluid (CSF) and sera from patients with multiple sclerosis (MS) or other conditions and from control subjects. In serum, visible fluorescence, A240nm, and free and protein-bound thiobarbituric acid (TBA)-reactive substances were significantly greater in MS patients than in control subjects. No such differences were observed in CSF. There was no correlation between lipid peroxides and disease severity or relapse time. We observed a significant positive correlation between CSF protein-bound TBA-reactive substances and CSF protein, suggesting that production of the former depends on protein concentration. A significant negative correlation between free TBA-reactive substances in serum and ultraviolet fluorescence indicated that production of free TBA-reactive substances may be associated with decreased production of fluorescent lipid peroxides. This study provides evidence for increased lipid peroxidation in serum but not CSF from MS patients, suggesting that either there is no increase in CSF lipid peroxidation in MS patients or that CSF lipid peroxides are rapidly removed, possibly by binding to CSF proteins that can be reabsorbed into the blood.


Subject(s)
Lipid Peroxidation , Lipid Peroxides/blood , Lipid Peroxides/cerebrospinal fluid , Multiple Sclerosis/blood , Multiple Sclerosis/cerebrospinal fluid , Adult , Humans , Middle Aged , Spectrometry, Fluorescence , Thiobarbiturates
10.
Article in Russian | MEDLINE | ID: mdl-1667836

ABSTRACT

The content of lactate and products of lipid peroxidation in the c. s. f. of infants with craniocerebral trauma was studied. The content of lactate and malonic dialdehyde in the c. s. f. was significantly increased, which correlated with the severity of the trauma. The results of the study make it possible to followup the course of the cerebral traumatic disease and the efficacy of the applied therapy and also may severe as prognostic criteria in evaluating the possible sequelae of the craniocerebral trauma.


Subject(s)
Brain Injuries/cerebrospinal fluid , Lactates/cerebrospinal fluid , Lipid Peroxides/cerebrospinal fluid , Acute Disease , Brain Concussion/cerebrospinal fluid , Child, Preschool , Humans , Infant , Lactic Acid , Lipid Peroxidation , Time Factors
12.
Clin Chem ; 36(1): 139-42, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2297906

ABSTRACT

Cerebrospinal fluid lipoperoxides, measured as the malondialdehyde-thiobarbituric acid (MDA-TBA) adduct, were quantified by adapting the plasma liquid-chromatographic method of Wong et al. (Clin Chem 1987;33:214-20) to cerebrospinal fluid. Reference values for spinal fluid specimens from 91 adults, ages 17 to 95 y, and 37 children, ages 8 d to 8 y, were determined. Their concentrations were not significantly different (P = 0.222), adults having a mean (and SD) of 0.11 (0.06) mumol and children 0.10 (0.04) mumol of MDA per liter. Their ranges were 0.02-0.26 and 0.04-0.21 mumol of MDA per liter, respectively. We found concentrations in cerebrospinal fluid to be increased in several central nervous system disorders, including seizures, cerebral infarction, alcoholic encephalopathy, and, perhaps, prematurity. The presence of other thiobarbituric acid-reactive substances in cerebrospinal fluid stresses the importance of using highly specific techniques when lipoperoxides are measured in body fluids.


Subject(s)
Lipid Peroxides/cerebrospinal fluid , Adolescent , Adult , Aged , Aged, 80 and over , Central Nervous System Diseases/cerebrospinal fluid , Child , Child, Preschool , Chromatography, Liquid , Female , Humans , Infant , Infant, Newborn , Lipid Peroxides/standards , Male , Malondialdehyde/analysis , Middle Aged , Reference Values , Thiobarbiturates/analysis
14.
J Cereb Blood Flow Metab ; 8(1): 1-8, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3339099

ABSTRACT

The relationship between free radical reactions and the defense mechanisms against them was investigated in the pathogenesis of prolonged vasospasm following experimental subarachnoid hemorrhage (SAH) in dogs. The concentration of lipid peroxides in the cerebro spinal fluid (CSF) increased markedly up to the eighth day following SAH; the concentrations also rose in the arterial wall (p less than 0.01) and the gray matter of the temporal lobe where the subarachnoid blood clots were (p less than 0.01). On the other hand, the activity of superoxide dismutase (SOD) decreased significantly up to the eighth day after SAH (p less than 0.01), and there was a gradual increase of glutathione peroxidase (GSH-px) in the CSF. In the arterial wall, there was a slight decrease in the activity of SOD, a significant decrease in the activity of GSH-px (p less than 0.01), and also a significant decrease in the concentration of glutathione (p less than 0.01) up to the eighth day following SAH. In conclusion, lipid peroxidation with insufficient biological defense mechanisms against it in the arterial wall, concomitant with that in the CSF, might take part in the genesis of prolonged vasospasm following SAH.


Subject(s)
Lipid Peroxides/metabolism , Subarachnoid Hemorrhage/complications , Vascular Diseases/etiology , Animals , Basilar Artery/pathology , Brain/metabolism , Cerebral Arteries/metabolism , Dogs , Free Radicals , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Histocytochemistry , Lipid Peroxides/cerebrospinal fluid , Parietal Lobe/metabolism , Pons/metabolism , Spasm , Subarachnoid Hemorrhage/metabolism , Subarachnoid Hemorrhage/pathology , Superoxide Dismutase/metabolism , Temporal Lobe/metabolism
17.
Stroke ; 17(2): 196-202, 1986.
Article in English | MEDLINE | ID: mdl-3961828

ABSTRACT

We examined the relationship between the biological protective mechanisms of scavengers and free radicals that are elicited by subarachnoid hemorrhage (SAH) in the pathogenesis of prolonged vasospasm following ruptured intracranial aneurysm. The study included 25 patients treated by early surgery (within 72 hours after SAH). Lipid peroxides concentrations and the activities of superoxide dismutase (SOD), catalase, and glutathione peroxidase (GSH-px) in the cerebrospinal fluid (CSF) were measured. The concentration of lipid peroxides increased significantly more (p less than 0.05) during the first 4 days after SAH in patients with symptomatic vasospasm than in those without. Patients with symptomatic vasospasm had a marked decrease in SOD activity on Days 3 and 4 followed by a gradual decrease, whereas the patients without spasm showed little change (difference between the groups, p less than 0.05). There was a significant difference in catalase activity reversal to SOD activity, but no difference in GSH-px activity. Thus, correlation was close between the increased lipid peroxides concentration and the decrease in SOD activity in CSF (p less than 0.05), suggesting an important mechanism in the pathogenesis of vasospasm.


Subject(s)
Intracranial Aneurysm/complications , Ischemic Attack, Transient/etiology , Adult , Aged , Catalase/cerebrospinal fluid , Chemical Phenomena , Chemistry , Female , Glutathione Peroxidase/cerebrospinal fluid , Humans , Ischemic Attack, Transient/cerebrospinal fluid , Lipid Peroxides/cerebrospinal fluid , Male , Middle Aged , Rupture, Spontaneous , Subarachnoid Hemorrhage/complications , Superoxide Dismutase/cerebrospinal fluid , Tomography, X-Ray Computed
18.
Neurochem Res ; 10(12): 1645-52, 1985 Dec.
Article in English | MEDLINE | ID: mdl-4088434

ABSTRACT

Lipid peroxidation (LPx) products were measured as thiobarbituric acid-reactive substances (TS) and lipid-soluble fluorescent pigments (FP) in both plasma and CSF from MS patients and controls. Although no significant changes were found in MS plasma, we report here for the first time increases in both TS and FP in MS CSF (p less than 0.05 and p less than 0.01, respectively, compared with patients with other neurological diseases), indicating that increased LPx in CNS may be a feature of MS. Levels of transferrin were normal but caeruloplasmin (CP), a major antioxidant plasma protein, was significantly raised in MS patients (p less than 0.01) and this may represent an adaptive response to increased oxidative challenge. Neither of these proteins was detectable in CSF using radial immunodiffusion. There was no significant correlation between the severity or duration of the disease nor the period since the last relapse and either LPx products or CP suggesting that the changes observed in this work are not simply the direct result of demyelination and tissue damage.


Subject(s)
Antioxidants/analysis , Lipid Peroxides/blood , Multiple Sclerosis/blood , Ceruloplasmin/blood , Ceruloplasmin/cerebrospinal fluid , Humans , Lipid Peroxides/cerebrospinal fluid , Malondialdehyde/blood , Malondialdehyde/cerebrospinal fluid , Multiple Sclerosis/cerebrospinal fluid , Pigments, Biological/blood , Pigments, Biological/cerebrospinal fluid , Spectrometry, Fluorescence , Transferrin/cerebrospinal fluid
20.
Biull Eksp Biol Med ; 96(11): 36-8, 1983 Nov.
Article in Russian | MEDLINE | ID: mdl-6416329

ABSTRACT

The development of focal or generalized epileptic activity (EA) in the rat brain cortex leads to the augmentation in the content of lipid peroxidation (LPO) products in the EA area (crude synaptosomes), diene conjugates, TBA-active products (products reacting with 2-thiobarbituric acid), and Schiff bases. LPO activation in the brain cortex during EA leads both to an increase in the level of Schiff bases in the cerebrospinal fluid and to a dramatic rise in the level of diene conjugates and Schiff bases in peripheral blood plasma.


Subject(s)
Cerebral Cortex/metabolism , Epilepsies, Partial/cerebrospinal fluid , Lipid Peroxides/cerebrospinal fluid , Animals , Epilepsies, Partial/blood , Lipid Peroxides/blood , Rats , Schiff Bases/analysis , Synaptosomes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...